Vanguard Personalized Indexing Management LLC Grows Position in Chemed Co. (NYSE:CHE)

Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Chemed Co. (NYSE:CHE) by 55.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,305 shares of the company’s stock after purchasing an additional 464 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Chemed were worth $763,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Moran Wealth Management LLC boosted its holdings in Chemed by 13.8% during the 4th quarter. Moran Wealth Management LLC now owns 38,975 shares of the company’s stock valued at $22,791,000 after acquiring an additional 4,735 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Chemed by 121.5% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 203,096 shares of the company’s stock valued at $118,760,000 after acquiring an additional 111,399 shares during the period. Envestnet Portfolio Solutions Inc. boosted its holdings in Chemed by 9.4% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 1,346 shares of the company’s stock valued at $787,000 after acquiring an additional 116 shares during the period. QRG Capital Management Inc. boosted its holdings in Chemed by 2.6% during the 4th quarter. QRG Capital Management Inc. now owns 1,341 shares of the company’s stock valued at $784,000 after acquiring an additional 34 shares during the period. Finally, Jump Financial LLC purchased a new position in Chemed during the 4th quarter valued at about $1,755,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CHE has been the topic of a number of analyst reports. Oppenheimer increased their price target on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Thursday, February 29th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Finally, Royal Bank of Canada reduced their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday.

Insider Transactions at Chemed

In other news, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the sale, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the sale, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now directly owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,808 shares of company stock valued at $12,454,691. Corporate insiders own 3.32% of the company’s stock.

Chemed Price Performance

CHE stock opened at $559.81 on Wednesday. The firm has a market capitalization of $8.47 billion, a P/E ratio of 30.13, a P/E/G ratio of 2.31 and a beta of 0.46. The business’s 50-day moving average is $606.37 and its two-hundred day moving average is $595.76. Chemed Co. has a 1 year low of $492.84 and a 1 year high of $654.62.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share for the quarter, missing the consensus estimate of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The business had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. On average, analysts expect that Chemed Co. will post 21.72 EPS for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, May 30th. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.